Concepedia

E. Dávila

ED

Statistics

Publications

8

Citations

177

H-Index

8

Active since

1984

Affiliations

University of California, San Francisco(Current)

E. Dávila is an author at University of California, San Francisco specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1984–2012

8

Publications

8

Prevalence and risk factors for metabolic syndrome in Medellin and surrounding municipalities, Colombia, 2008–2010

E. Dávila, Maryi A. Carvajal Quintero, MAITE ORREGO et al. · Preventive Medicine · 2012 · 40 citations

, , +16

Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial.

Mario J. R. Ravry, G A Omura, Alfred A. Bartolucci et al. · PubMed · 1986 · 31 citations

, , +16

Multimodality treatment of non‐small cell lung cancer: Response to cisplatin, VP‐16, and 5‐FU chemotherapy and to surgery and radiation therapy

K. S. Sridhar, Richard J. Thurer, Y. Kim et al. · Journal of Surgical Oncology · 1988 · 28 citations

, , +16

Management of locally advanced breast cancer (stage III): a review.

E. Dávila, Charles L. Vogel · PubMed · 1984 · 22 citations

, , +17

A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008

Walter M. Stadler, Susan Halabi, Marc S. Ernstoff et al. · Journal of Clinical Oncology · 2004 · 16 citations

, , +11

1–5 of 8